Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Randomized Double-Blind Comparative Study of Flexible Dosing of Paliperidone and Risperidone in Schizophrenia
2006-003560-62Phase 3Completed
- Sponsor
- Janssen Pharmaceutical
- Start
- Oct 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of paliperidone in schizophrenia (4 arms), sponsored by Janssen Pharmaceutical. Primary endpoint: Change from baseline in total schizophrenia severity score. Started Oct 2006; status: completed.
02
Drugs
paliperidone
03
Conditions
schizophrenia
Beyond the preview
Go deeper on 2006-003560-62.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-003560-62.